Trehalose administration in C57BL/6N old mice affects healthspan improving motor learning and brain anti-oxidant defences in a sex-dependent fashion: a pilot study by Berry, A. et al.
Contents lists available at ScienceDirect
Experimental Gerontology
journal homepage: www.elsevier.com/locate/expgero
Short report
Trehalose administration in C57BL/6N old mice affects healthspan
improving motor learning and brain anti-oxidant defences in a sex-
dependent fashion: a pilot study
Alessandra Berrya,⁎, Matteo Marconib, Chiara Musilloa, Flavia Chiarottia, Veronica Bellisarioa,
Paola Matarreseb, Lucrezia Gambardellab, Rosa Vonab, Maria Lombardic, Chiara Foglienic,
Francesca Cirullia
a Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
bNational Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
c Cardiovascular Research Area, San Raffaele Scientific Institute IRCCS, Milan, Italy
A R T I C L E I N F O
Section Editor: Thomas Foster
Keywords:
Mouse model
Aging
Trehalose
Oxidative stress
Sex-differences
Behaviour
A B S T R A C T
Aim of this study was to characterize the effects of oral trehalose administration (2%w/v) on healthspan in old
mice. Trehalose was administered in drinking water for 1month to male and female C57BL/6N mice aged 25-
months. After behavioral phenotyping (grip strength, beam walking and rotarod tests), autophagy (LC3-II/actin)
and oxidative stress were tested in the cerebral cortex and gastrocnemius muscle. The latter parameter was
indirectly assessed by evaluating carbonyl groups added to proteins as a result of oxidative reactions, in addition
to central levels of NRF2 protein, a transcription factor that regulates the expression of antioxidant enzymes. In
comparison with sex-matched controls, trehalose-treated males performed better in motor planning and co-
ordination tasks. This behavioral phenotype was associated with an activation of the ubiquitin-proteasome
system, autophagy and antioxidant defences in cerebral cortex. Independently from trehalose administration,
females were characterized by better motor performance and showed higher levels of ubiquitinated proteins and
NRF2 in cerebral cortex, suggesting an up-regulation of basal antioxidant defences. In conclusion, trehalose was
effective in counteracting some aspects of age-related decay, with specific effects in male and female subjects.
1. Introduction
Oxidative stress (OS) is a major component of aging that may cause
molecular damage, cells and tissues dysfunction, compromising the
health status of the organism (healthspan) (Berry and Cirulli, 2013;
Fischer et al., 2016; Floyd and Hensley, 2002; Fuellen et al., 2018). Of
notice, the mammalian brain shows poor antioxidant defences, high
metabolic rate and reduced capability of cellular regeneration, being
particularly vulnerable to OS insults (Floyd and Hensley, 2002). A wide
range of approaches have been designed to reduce OS in order to in-
crease lifespan and to promote healthspan. Among these, we can enlist
caloric restriction (CR), namely a reduced caloric intake without mal-
nutrition (Loeb and Northrop, 1917; Mattison et al., 2007; Most et al.,
2017). Despite CR being an effective strategy to slow down the aging
process, the feasibility of such intervention is tricky in a lifelong per-
spective, leading to reduced compliance in the general population, and
possibly being unsafe for normal-weight, middle-aged and elder adults
(Martens and Seals, 2016; Villareal et al., 2016).
Trehalose is an alpha-linked disaccharide of glucose synthesized by
fungi, plants and invertebrates, but not by mammalian cells, potentially
displaying CR-mimetic properties (Martens and Seals, 2016). Trehalose
has been reported to function as a mechanistic target of the rapamycin
(m-TOR)-independent inducer of autophagy (Mizunoe et al., 2018;
Rodriguez-Navarro et al., 2010). In particular, trehalose-mediated in-
hibition of glucose transport might create a functionally “starved” state
enhancing positive or bypassing aberrant energy-sensing signalling
pathways that are dysregulated during the aging process (DeBosch
et al., 2016; Martens and Seals, 2016).
A growing body of evidence in animal models suggests that ad-
ministration of trehalose leads to increased lifespan and improved
healthspan (Portbury et al., 2017; Sarkar et al., 2014; Tanaka et al.,
2004). Despite these promising results, before this compound can be
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employed for human use, further studies detailing its mechanisms of
action need to be carried-out. In this context, it is important to highlight
the yet general scarcity of knowledge about sex-differences in response
to food restriction or to CR-mimetic compounds that are emerging as
promising anti-aging alternatives to food-restriction regimens
(Anisimov et al., 2015; Piotrowska et al., 2016).
The aim of this pilot study was to explore the effects of oral treha-
lose administration on motor behavior, OS and autophagy in a murine
model of physiological aging, taking into account sex differences and
comparing central (brain) vs. peripheral effects. Thus, we selected 25-
month-old C57BL/6N mice since this is one of the most commonly used
strains for whom a growing body of data on the aging phenotype is
starting to be available also with regard to sex differences. As an ex-
ample, Baumann and co-workers, in a very recent and interesting paper,
report that in this strain, at 26months of age, the prevalence of frailty is
66% greater in females than males, males live 13% longer than females,
females being characterized by greater physical activity in the volun-
tary wheel run, reduced endurance on the treadmill. Furthermore,
when body composition was evaluated, females showed greater amount
of fat percentage (Baumann et al., 2019). Since it has been recently
suggested that trehalose might protect from OS by regulating the
KEAP1-NRF2 and autophagy pathways (Mizunoe et al., 2018) we in-
directly assessed levels of OS by evaluating carbonyl groups present
into proteins as a result of oxidative reactions, in addition to central
levels of the NRF2 protein, a transcription factor that regulates the
expression of antioxidant enzymes. Moreover, levels of autophagy were
assessed by evaluating levels of LC3-II, the main autophagosomal
marker (Tanida et al., 2008).
2. Materials and methods
2.1. Experimental subjects and trehalose administration
Twenty-four male and twenty-two female mice aged 25-months of
the C57BL/6N strain (Charles River) were housed under standard
conditions at the animal facility of Istituto Superiore di Sanità (Berry
et al., 2018). All subjects were housed 2–3/cage with a same-sex con-
specific. Twelve males and eleven females were administered either
with 2% trehalose w/v (Sigma Aldrich) or with regular tap water (12
males and 11 females) for 30 days. A fresh solution was prepared twice/
week. Since we have data to show that 24-month-old C57BL/6N mice
drink, on average, 5 ml of water each day (unpublished results) we
calculated that each mouse received roughly 0.1 mg trehalose/die. The
trehalose dose has been selected based on its efficacy, as reported in
previous studies carried-out on different mouse models (particularly of
neurodegenerative disorders) involving a dysregulation of the autop-
hagic process (Kara et al., 2013; Schaeffer et al., 2012; Tanaka et al.,
2004; Tanji et al., 2015). Before starting trehalose administration, body
weight was registered and all subjects underwent a basal assessment of
physical strength (grip strength) and motor coordination (beam
walking). Body weight was recorded each week (by the time fresh so-
lutions were prepared). At the end of treatment, mice were re-assessed
for physical strength (grip strength) and motor coordination (beam
walking and rotarod tests) and sacrificed immediately after. Brains
(frontal cortex) and limb muscles (gastrocnemius) were dissected-out
and frozen for further analyses (see Fig. 1 for an experimental timeline).
All experimental procedures were conducted in conformity with the
European Directive 2010/63/EU and the Italian legislation on animal
experimentation, D.Lgs.vo 26/2014 and were approved by the Istituto
Superiore di Sanità Ethical Committee (Organismo Preposto per il
Benessere Animale - OPBA) and by the Italian Ministry of Health.
2.2. Behavioral phenotyping
2.2.1. Grip strength
The grip strength is a main measure of muscular strength used for
mice. Mice instinctively hold on to materials with a strong grip. This
test is commonly used to assess gross changes in this parameter in
different pathological conditions (e.g. animal models of Parkinson's
disease and Huntington's chorea). The ability to remain clinging, with
all four paws, to an inverted or tilted surface (a cage lid) was tested for
a period of time up to 60 s (cut-off). A small surface was delimited to
avoid the movement of subjects into the cage lid for a more reliable
assessment of muscles strength (Deacon, 2013b).
2.2.2. Beam walking
Fine changes in motor coordination and balance in response to
trehalose administration were evaluated assessing the ability of mice to
traverse two narrow beams of different diameter. The goal of this test is
for the mouse to stay upright and walk across an elevated narrow beam.
The motivation to perform the task is provided by a safe platform po-
sitioned at the end of the beam (Curzon et al., 2009). Beams were
placed horizontally, 50 cm above the table. Mice were first trained to
traverse a beam of 2 cm in diameter (1° BEAM) and 2 h later a beam of
1 cm in diameter (2° BEAM), to increase the task difficulty. Latency to
traverse each beam, within the allotted time (cut-off 60 s), was recorded
as well as the number of subjects that fell off the beams before and after
treatment administration (Deacon, 2013a).
2.2.3. Rotarod
Accelerated rotarod training can be regarded as a valid paradigm for
motor skill learning over short (intra-session, minutes) and long time
frames (inter-session, days) (Buitrago et al., 2004). Changes in motor
learning, coordination and balance in response to trehalose adminis-
tration were tested using an accelerating rotarod (Accelerating Rotarod,
Ugo Basile, Gemonio, Italy) (Curzon et al., 2009). Mice with deficits in
motor coordination or balance fall off the rotarod before the end of the
5-minute test session (Crawley, 1999). The test has been performed by
placing a mouse on a rotating rod with a diameter of 3 cm and mea-
suring the latency to fall (in seconds) through a switch placed on the
floor below. Mice were given three trials each with a maximum time of
300 s (5min), during which time the rotating rod underwent a linear
acceleration from 4 to 40 rpm over 5min. Animals were rested after a
minimum of 10min between trials to avoid fatigue (Paylor et al., 2006).
Differently from the beam walking, this test of motor learning was
performed only once (at the end of the treatment) to prevent a ceiling
effect due to overtraining.
2.3. Analyses on peripheral and central tissues
2.3.1. Western blot
Brain and muscle tissues were lysed in lysis buffer containing 1%
Triton X-100, 10mM Tris–HCl (pH 7.5), 150mM NaCl, 5 mM EDTA,
1mM Na3VO4 and 75 U of aprotinin and allowed to stand for 20min at
4 °C. The tissue suspension was disrupted by Dounce homogenization
(ten strokes) and then centrifuged for 5min at 1300×g to remove
nuclei and large cellular debris. After evaluation of the protein con-
centration by Bradford dye reagent assay (Bio-Rad, 500-0006), the ly-
sate was subjected to sodium-dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE), protein loading: 30 μg/lane. Proteins were
electrophoretically transferred onto polyvinylidene difluoride (PVDF)
membranes (Bio-Rad, 162-0177). Membranes were blocked with 5%
defatted dried milk in TBS, containing 0.05% Tween-20 and probed
with rabbit polyclonal anti-LC3 antibody (MBL Int Corporation,
PD014), with rabbit monoclonal anti-Nuclear Factor Erythroid 2-re-
lated Factor 2 (NRF2, Abcam, ab62352), with mouse monoclonal anti-
beta-actin (Sigma, A5316), with mouse monoclonal anti-Ubiquitin
(Abcam, ab7254). Bound antibodies were visualized with horseradish
peroxidase (HRP)-conjugated anti-rabbit IgG (Sigma, A1949) or anti-
mouse IgG (Sigma, A9044) and immunoreactivity assessed by chemi-
luminescence reaction, using the ECL western detection system
(Amersham, RPN2106). Densitometric scanning analysis was
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performed with Mac OS X (Apple Computer International), using NIH
ImageJ 1.62 software.
2.3.2. Protein carbonyl assay
Carbonyl groups present into proteins as a result of oxidative re-
actions were evaluated in brain tissue with Oxidized Protein Western
blot detection (Abcam, ab178020; Cambridge, MA, USA).
Twentymicrograms protein load was used in all groups; protein car-
bonyl groups were measured according to the manufacturer's instruc-
tions.
2.4. Statistical analysis
For those endpoints following a normal distribution (body weight,
NRF2, carbonyl groups, ubiquitinated proteins and LC3-II) data were
analysed using an exploratory 2-way-ANOVA with Treatment and Sex
as between-subjects factors and repeated measure a within subject
factor (body weight). Since a main effect of sex was found on all the
parameters taken into account, to better characterize the effects of
trehalose, male and female subjects were analysed separately by means
of a one-way-ANOVA with only Treatment as a between subjects factor.
In more detail: the effect on body weight was evaluated (separately in
males and females) by looking at the difference between day 30 (last
day before sacrifice) and day 0 and then transforming raw data in
percentage change with respect to basal body weight (day 0). For ex-
vivo parameters raw data were transformed to percentage change
compared to the appropriate control (either male or female). Latencies
to fall in the grip strength and rotarod were analysed with the non-
parametric Mann and Whitney test (data were transformed to percen-
tage change from basal value separately for males and females). For the
beam walking, the McNemar's change test (a simple and frequently
used test for binary matched-pairs data (Fagerland et al., 2013) was
applied to evaluate changes in the motor performance from day 0 to
day 30 of each single subject within each group of treatment. In more
detail, a fall off the beam on day 0, but not on day 30, was considered as
an improvement while a fall only on day 30 was considered as a wor-
sening; subjects falling or not falling on both days were accounted
within the “stable performance” group. Grubb's test (using 5% sig-
nificance level critical values, (Grubbs, 1950)) was used to detect out-
liers in the case of data following a normal distribution. Statistical
analysis was performed using Statview II (Abacus Concepts, CA) and
GraphPad Prism 7. A significance level of 0.05 was chosen. See Sup-
plementary Tables S1 and S2 for mean and SEM of all the parameters
analysed by ANOVA and median values, minimum, maximum and in-
terquartile rates for all parameters analysed by means of non-para-
metric analyses.
3. Results
3.1. Body weight and behavioral phenotyping
3.1.1. Body weight
As expected male subjects showed higher body weight than females
(sex main effect: F(1,42)= 10.261; p=0.026; mean ± SEM:
28.5 ± 1.9 and 30.4 ± 2.2 respectively for females and males). When
males and females were analysed separately, trehalose treatment was
able to counteract the age-dependent decrease in body weight observed
in females (F(1,20)= 5.411; p= 0.0306) but not in males (F
(1,22)= 0.678; p= 0.4192), see Fig. 2a.
3.1.2. Grip strength
No difference was found as a result of trehalose administration
(females: U(11,11)= 52.000; p=0.5761; males: U(12,12)= 63.000;
p=0.6033).
3.1.3. Beam walking
Females showed a worsening in their performance over time when
traversing the 1° BEAM (broad beam: p=0.0269) but not the 2°
(narrow beam: p= 0.267) while the opposite was observed in males
(larger beam: p= 1.000; smaller beam: p=0.0159).
No difference was found over time neither in control (p= 0.1306)
nor in trehalose-treated subjects (p= 0.2207) on the 1° BEAM. By
contrast, on the 2° BEAM - requiring more refined motor coordination
abilities - trehalose-treated mice maintained a stable performance
(p= 0.1824, see Fig. 2b) while control subjects showed a worsening in
motor function over time (p= 0.0389).
3.1.4. Rotarod
No difference was found as a result of treatment in trials 1 and 2
neither for females nor for males (females, trial 1: U(11,11)= 55.000;
p=0.7178; trial 2: U(11,11)= 47.000; p= 0.3750; males, trial 1: U
(12,12)= 68.000; p= 0.8173; trial 2: U(12,12)= 51.500;
Fig. 1. Timeline of the experimental plan.
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p=0.2365). However, on trial 3, trehalose improved the motor per-
formance of male subjects (males: U(12,12)= 30.500; p=0.0165; fe-
males: U(11,11)= 48.500; p=0.4304); Fig. 2c.
3.2. Analyses on peripheral and central tissues
In some cases, following the extraction procedure, tissue was not
sufficient to carry-out all the ex-vivo assessments on all the experi-
mental subjects; in the specific case of carbonyl groups 1 ctrl male and 1
trehalose-treated male were found to be outliers and were excluded
from the analysis; likewise 1 ctrl male and 1 trehalose-treated female
were excluded from the analysis when assessing ubiquitinated proteins
in the frontal cortex. Thus, the final number of the samples available for
each sex and treatment and for each tissue was between 8 and 12 (see
Supplementary Tables S1 and S2).
3.2.1. Analysis of oxidative markers in frontal cortex
When OS markers were assessed in the frontal cortex, a main effect
of sex was found with females showing elevated levels of carbonyl
groups (F(1,33)= 14.322, p=0.0006, mean ± SEM: 3.093 ± 0.617
and 0.307 ± 0.042 respectively for females and males). Data expressed
as % change to control and separately analysed in males and females
showed no difference as a result of treatment neither in females nor in
males (females: F(1,19)= 0.949; p= 0.3423; males: F
(1,14)= 9.3410–6; p= 0.9976, see Fig. 3a). A main effect of sex was
found for NRF2 with females being characterized by higher protein
levels (F(1,38)= 9.940; p=0.0032, mean ± SEM: 0.452 ± 0.0089
and 0.151 ± 0.042 respectively for females and males, data not
shown). Data expressed as % change to control and separately analysed
for males and females, showed that males were characterized by in-
creased NRF2 levels as a result of treatment (F(1,20)= 4.604,
p=0.0444), this was not observed in females (F(1,18)= 0.539;
p=0.4721), see Fig. 3b.
3.2.2. Autophagy (LC3II/actin)
A main effect of sex was found with male subjects showing greater
autophagic rate when compared to females in the frontal cortex (F
(1,40)= 8.391; p= 0.0061, mean ± SEM: 0.179 ± 0.018 and
0.314 ± 0.049 respectively for females and males). Data expressed as
% change to control, and separately analysed for males and females,
revealed that trehalose increased LC3-II/actin ratio levels only in males
(males: F(1,20)= 7.006; p= 0.0155; females: F(1,20)= 1.428;
p=0.2460, Fig. 3c). No effect of treatment was observed in the gas-
trocnemius muscle (males: F(1,19)= 0.381; p= 0.544; females: F
(1,19)= 1.046; p= 0.3192, Fig. 4a).
3.2.3. Ubiquitination (ubiquitin/actin)
A significant sex x treatment interaction (F(1,39) 5.870;
p=0.0201, see also Supplementary Table S1) was found in the frontal
cortex. Data expressed as % change to control and separately analysed
for males and females revealed that trehalose-treated males showed a
strong trend towards increased levels of ubiquitinated proteins (F
(1,20)= 4.272; p=0.0519) while treatment administration did not
affect this parameter in females (F(1,19)= 2.602; p=0.1232); see
Fig. 3d. Trehalose did not affect ubiquitinated protein levels in the
gastrocnemius muscle (males: F(1,18)= 0.144; p=0.7083; females: F
(1,20)= 0.016; p= 0.9010); see Fig. 4b.
4. Discussion
Results from this study show that one month of oral trehalose ad-
ministration leads to positive sex-dependent effects in senescent mice.
In more detail, trehalose prevented the age-related decrease in body
weight in old females, while improving motor function in males, this
latter effect being accompanied by increased levels of NRF2 and of
autophagy in the frontal cortex. These effects were specific for the brain
and were not observed in muscles.
Trehalose was able to reduce the sharp decrease in body weight in
female subjects just before sacrifice. The weight loss observed in fe-
males has been previously reported by Fahlström and colleagues in
C57BL/6 females older than 20months (Fahlstrom et al., 2011) and
might suggest a general worsening due to the progression of aging that
is more apparent in this sex. Indeed, as reported by Kunstyr and
Leuenberger, 25months of age for C57BL/6 mice is a commonly ac-
cepted landmark for lifespan since at this age mortality rate is about
50% (Kunstyr and Leuenberger, 1975). Moreover, with regard to sex-
differences, although environmental conditions might greatly affect this
parameter, a consistent number of evidence suggest that, at least for
Fig. 2. Trehalose counteracted the age-dependent decrease in body weight observed in females (a), prevented the time-dependent decrease in motor function in all
mice tested on the beam walking (narrow beam) (b) and improved motor learning in male subjects in the rotarod test (c). Data are presented as: mean+ SEM (a);
percentage of subjects falling off the beam (b); box plot (c). Observations outside these ranges in the box plot are represented with dots outside the boxes.*p < 0.05.
Experimental subjects in each final group: F, control= 11, trehalose=11; M, control= 12, trehalose= 12.
A. Berry, et al. Experimental Gerontology 129 (2020) 110755
4
this strain, females have a shorter lifespan than males (see (Austad and
Fischer, 2016) and references therein for a complete review). To this
regard, the protective effect of trehalose on body weight might suggest
that 25–26months of age may represent a critical window of oppor-
tunity for healthspan-promoting treatment administration.
Trehalose treatment prevented the time-dependent decrease in
motor function in all mice tested on the narrow beam reducing the
number of subjects falling-off the beam over time. Moreover, we ob-
served a specific and sex-dependent improvement in motor learning
after trehalose administration as assessed in the rotarod test. In general,
improvements in the rotarod test are not only the result of enhanced
locomotor abilities or fitness, that may be trained in the running wheel,
but rather rely on specific changes in motor strategies that are needed
in order to master this motor test. In fact, differently from other motor
tasks, mice must learn to associate sensory states (proprioceptive, ves-
tibular, position in space and on the rod) with the appropriate motor
response to facilitate remaining on the accelerating rotating rod rather
than falling (Beeler et al., 2010; Buitrago et al., 2004). The difference
between simple motor performance and motor learning is clearly ap-
parent in animal models of Parkinson's disease. For example Beeler and
co-workers found that PITx3-deficient mice do not display motor
deficits unless they are assessed in more complex tasks that require
learning of new motor skills, such as the rotarod test (Beeler et al.,
2010). Our results show that trehalose treatment improved motor
learning in males only (trial 3). Some evidence suggests that females
perform better than males in motor coordination/motor balance tests.
As an example, Oliveira and colleagues found that female C57BL6 mice
outperformed males both in the rotarod as well as in the beam walking
test, showing a shorter latency to cross the beam and a higher latency to
fall off the accelerated rod (Oliveira et al., 2015). Moreover, Jung and
Metzger showed that female rats were characterized by a better per-
formance compared to males on the rotarod, upon an oxidative insult,
suggesting that the cerebellum, that is involved in motor learning,
might be a preferred target for these regulations (Jung and Metzger,
2016). Although we did not analyse this specific brain area, we can
hypothesize that trehalose might specifically improve motor learning
abilities, rather than muscle-related motor function, in the sex showing
the worst performance, possibly through mechanisms involving central
modulation of OS status. This piece of data is partially supported by the
observed increase in the levels of NRF2 and autophagy in the frontal
cortex (but not in limb muscle) of trehalose-treated male mice. Our
observations are in line with very recent evidence by Mizunoe and
Fig. 3. Quantification of carbonyl groups was not affected by trehalose treatment (a). Trehalose increased NRF2 levels in males (b). Trehalose increased the
autophagic rate in the brain of male subjects (c). A strong trend was observed in males towards increased ubiquitinated proteins upon trehalose treatment (d).
Densitometric analysis data are shown as mean+SEM *p < 0.05. Protein levels of LC3-II, ubiquitinated proteins and NRF2 protein levels, carbonyl groups and actin
were analysed by western blot. Actin served as loading control. Representative blots are shown. Subjects for each group: autophagy (LC3-II): F, control= 11;
trehalose=11; M, control = 11; trehalose= 11; ubiquitinated proteins: F, control = 11; trehalose=10; M, control= 10; trehalose= 12; Nrf2: F, control= 9;
trehalose=11; M, control= 12; trehalose= 12; carbonyl groups: F, control = 10; trehalose=11; M, control= 8; trehalose=8.
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colleagues suggesting that trehalose, acting as an antioxidant, protects
against OS by regulating the KEAP1–NRF2 and autophagy pathways
(Mizunoe et al., 2018). In more detail, trehalose might be able to pro-
mote the nuclear translocation and transcriptional activity of NRF2 -
that triggers the transcription of downstream target genes encoding for
antioxidant enzymes - as well as the activation of the autophagic ma-
chinery. As far as autophagy is concerned, this is an essential cellular
function that regulates cellular homeostasis by degrading organelles
and proteins. Worth noticing, disruption of autophagy has been asso-
ciated with multiple pathological conditions ranging from cancer and
metabolic disorders to neuro-inflammation and neurodegeneration
(Nedelsky et al., 2008), all issues that may negatively impact on the
quality of life during aging.
There are data to indicate that the brain of female mice is char-
acterized by higher antioxidant capacity throughout life, including
aging (Berry et al., 2012; Guevara et al., 2009; Sobocanec et al., 2003).
Indeed, we found that female mice showed increased NRF2 levels, when
compared to males. Thus, once again it is possible to hypothesize that
the trehalose-dependent increase in NRF2 protein levels occurs in the
sex that is more vulnerable (i.e. males). These results are in line with
previous data from our group showing that females prenatally exposed
to the antioxidant N-acetyl-cysteine, in association with a high-fat diet,
are more resistant to changes in glutathione levels in the central ner-
vous system compared to males, while the opposite holds true in the
periphery (Berry et al., 2018).
Although there is a growing interest in understanding the me-
chanisms underlying sex differences in healthspan, these are still far
from a complete comprehension and the role played by sex hormones
throughout life (from early life to senescence) should not be neglected
(Austad and Fischer, 2016). To this regard, it is well known that es-
trogens hold anti-oxidant and anti-inflammatory properties and we
could speculate that this might explain, at list in part, the observed
increased basal levels of NRF2 in the brain of old females. This result is
also in line with our previous data showing preserved neurogenesis only
in the brain of old p66Shc−/− mice an animal model of reduced OS
(Berry et al., 2012).
As far as autophagy is concerned, both chromosomal make up as
well as sex hormones may affect this important intracellular remodel-
ling system throughout life, both in central and peripheral tissues.
Within the brain, sex steroids are able to affect the process of autophagy
through insulin and neurotrophic signalling, or through steroid re-
ceptors on mitochondria (Congdon and Sigurdsson, 2018; Tao et al.,
2018). Thus, although we did not observe differences in basal levels of
autophagy between males and females, but only in males as a result of
treatment administration, we cannot exclude that different doses of
trehalose might be required to modulate this system in a sex-dependent
fashion. Further studies should address this issue.
5. Concluding remarks
Taken together, our data, although preliminary, suggest that oral
trehalose administration leads to improved healthspan in old mice in a
sex-dependent fashion with no overt side effects. Mechanisms poten-
tially involved in the beneficial effects of trehalose seem to rely upon
both the activation of the NRF2 pathway - and the consequent im-
provement in antioxidant defences - as well as to a fine modulation of
autophagy; these mechanisms might be toned-down differentially by
the aging process in male and female subjects. Further studies will need
to carefully address sex differences identified in response to trehalose
administration taking also into account the mechanisms underlying the
crosstalk between peripheral and central tissues. Moreover, it would be
worth assessing whether the observed improvement in healthspan, after
a short-term trehalose administration (started at senescence), might
also increase longevity.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.exger.2019.110755.
Fig. 4. Trehalose treatment did not affect neither the autophagic rate (a) nor levels of ubiquitinated proteins (b) in the gastrocnemius muscle. Data from densito-
metric analysis are shown as mean+ SEM Protein levels of LC3-II, ubiquitinated protein and actin (control for sample loading) were analysed by western blot.
Representative blots are shown. Subjects for each group: autophagy (LC3-II): F, control = 11; trehalose=10; M, control = 10; trehalose= 11; ubiquitinated pro-
teins: F, control = 11; trehalose=11; M, control= 9; trehalose=11.
A. Berry, et al. Experimental Gerontology 129 (2020) 110755
6
Acknowledgments
We kindly acknowledge Gaia De Cristofaro for behavioral pheno-
typing and data analysis, Barbara Collacchi for technical assistance on
biochemical assessments and Luigia Cancemi and Francesca Ubaldi for
optimal animal care assistance.
Funding
Funding for this research were provided by Horizon 2020
Framework Programme; H2020 AwE “Ageing with Elegans” [grant
agreement N. 633589].
Conflicts of interest
The authors declare that there is no conflict of interest regarding the
publication of this paper.
Contribution statement
A.B. and M.M. designed all the experiments, carried out the statis-
tical analyses and wrote the paper; F.C. designed all the experiments
and wrote the paper; V.B. carried out all the behavioral experiments;
R.V. and L.G. performed autophagy and ubiquitination analyses; P.M.
and C.M. carried-out the analysis of oxidative markers and wrote the
paper; C.F., M.L. and F.C. carried-out the statistical analysis and con-
tributed to paper writing.
References
Anisimov, V.N., Popovich, I.G., Zabezhinski, M.A., Egormin, P.A., Yurova, M.N.,
Semenchenko, A.V., Tyndyk, M.L., Panchenko, A.V., Trashkov, A.P., Vasiliev, A.G.,
Khaitsev, N.V., 2015. Sex differences in aging, life span and spontaneous tumor-
igenesis in 129/Sv mice neonatally exposed to metformin. Cell Cycle 14, 46–55.
Austad, S.N., Fischer, K.E., 2016. Sex differences in lifespan. Cell Metab. 23, 1022–1033.
Baumann, C.W., Kwak, D., Thompson, L.V., 2019. Sex-specific components of frailty in
C57BL/6 mice. Aging (Albany NY) 11, 5206–5214.
Beeler, J.A., Cao, Z.F., Kheirbek, M.A., Ding, Y., Koranda, J., Murakami, M., Kang, U.J.,
Zhuang, X., 2010. Dopamine-dependent motor learning: insight into levodopa’s long-
duration response. Ann. Neurol. 67, 639–647.
Berry, A., Cirulli, F., 2013. The p66(Shc) gene paves the way for healthspan: evolutionary
and mechanistic perspectives. Neurosci. Biobehav. Rev. 37, 790–802.
Berry, A., Amrein, I., Notzli, S., Lazic, S.E., Bellisario, V., Giorgio, M., Pelicci, P.G., Alleva,
E., Lipp, H.P., Cirulli, F., 2012. Sustained hippocampal neurogenesis in females is
amplified in P66(Shc-/-) mice: an animal model of healthy aging. Hippocampus 22,
2249–2259.
Berry, A., Bellisario, V., Panetta, P., Raggi, C., Magnifico, M.C., Arese, M., Cirulli, F.,
2018. Administration of the antioxidant N-acetyl-cysteine in pregnant mice has long-
term positive effects on metabolic and behavioral endpoints of male and female
offspring prenatally exposed to a high-fat diet. Front. Behav. Neurosci. 12, 48.
Buitrago, M.M., Schulz, J.B., Dichgans, J., Luft, A.R., 2004. Short and long-term motor
skill learning in an accelerated rotarod training paradigm. Neurobiol. Learn. Mem.
81, 211–216.
Congdon, E.E., Sigurdsson, E.M., 2018. Tau-targeting therapies for Alzheimer disease.
Nat. Rev. Neurol. 14, 399–415.
Crawley, J.N., 1999. Behavioral phenotyping of transgenic and knockout mice: experi-
mental design and evaluation of general health, sensory functions, motor abilities,
and specific behavioral tests. Brain Res. 835, 18–26.
Curzon, P.; Zhang, M.; Radek, R.J.; Fox, G.B. The Behavioral assessment of sensorimotor
processes in the mouse: acoustic startle, sensory gating, locomotor activity, rotarod,
and beam walking. in: nd, Buccafusco J.J., eds. Methods of Behavior Analysis in
Neuroscience. Boca Raton (FL); 2009.
Deacon, R.M., 2013a. Measuring motor coordination in mice. J. Vis. Exp. e2609.
Deacon, R.M., 2013b. Measuring the strength of mice. J. Vis. Exp. 2.
DeBosch, B.J., Heitmeier, M.R., Mayer, A.L., Higgins, C.B., Crowley, J.R., Kraft, T.E., Chi,
M., Newberry, E.P., Chen, Z., Finck, B.N., Davidson, N.O., Yarasheski, K.E., Hruz,
P.W., Moley, K.H., 2016. Trehalose inhibits solute carrier 2A (SLC2A) proteins to
induce autophagy and prevent hepatic steatosis. Sci. Signal. 9, ra21.
Fagerland, M.W., Lydersen, S., Laake, P., 2013. The McNemar test for binary matched-
pairs data: mid-p and asymptotic are better than exact conditional. BMC Med. Res.
Methodol. 13, 91.
Fahlstrom, A., Yu, Q., Ulfhake, B., 2011. Behavioral changes in aging female C57BL/6
mice. Neurobiol. Aging 32, 1868–1880.
Fischer, K.E., Hoffman, J.M., Sloane, L.B., Gelfond, J.A., Soto, V.Y., Richardson, A.G.,
Austad, S.N., 2016. A cross-sectional study of male and female C57BL/6Nia mice
suggests lifespan and healthspan are not necessarily correlated. Aging (Albany NY) 8,
2370–2391.
Floyd, R.A., Hensley, K., 2002. Oxidative stress in brain aging. Implications for ther-
apeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795–807.
Fuellen, G., Jansen, L., Cohen, A.A., Luyten, W., Gogol, M., Simm, A., Saul, N., Cirulli, F.,
Berry, A., Antal, P., Köhling, R., Wouters, B., Möller, S., 2018. Health and aging:
unifying concepts, scores, biomarkers and pathways. Aging Dis. 10, 883–900.
Grubbs, F.E., 1950. Sample criteria for testing outlying observations. Ann. Math. Stat. 21,
27–58.
Guevara, R., Santandreu, F.M., Valle, A., Gianotti, M., Oliver, J., Roca, P., 2009. Sex-
dependent differences in aged rat brain mitochondrial function and oxidative stress.
Free Radic. Biol. Med. 46, 169–175.
Jung, M.E., Metzger, D.B., 2016. A sex difference in oxidative stress and behavioral
suppression induced by ethanol withdrawal in rats. Behav. Brain Res. 314, 199–214.
Kara, N.Z., Toker, L., Agam, G., Anderson, G.W., Belmaker, R.H., Einat, H., 2013.
Trehalose induced antidepressant-like effects and autophagy enhancement in mice.
Psychopharmacology 229, 367–375.
Kunstyr, I., Leuenberger, H.G., 1975. Gerontological data of C57BL/6J mice. I. Sex dif-
ferences in survival curves. J. Gerontol. 30, 157–162.
Loeb, J., Northrop, J.H., 1917. What determines the duration of life in Metazoa? Proc.
Natl. Acad. Sci. U. S. A. 3, 382–386.
Martens, C.R., Seals, D.R., 2016. Practical alternatives to chronic caloric restriction for
optimizing vascular function with ageing. J. Physiol. 594, 7177–7195.
Mattison, J.A., Roth, G.S., Lane, M.A., Ingram, D.K., 2007. Dietary restriction in aging
nonhuman primates. Interdiscip. Top. Gerontol. 35, 137–158.
Mizunoe, Y., Kobayashi, M., Sudo, Y., Watanabe, S., Yasukawa, H., Natori, D., Hoshino,
A., Negishi, A., Okita, N., Komatsu, M., Higami, Y., 2018. Trehalose protects against
oxidative stress by regulating the Keap1-Nrf2 and autophagy pathways. Redox Biol.
15, 115–124.
Most, J., Tosti, V., Redman, L.M., Fontana, L., 2017. Calorie restriction in humans: an
update. Ageing Res. Rev. 39, 36–45.
Nedelsky, N.B., Todd, P.K., Taylor, J.P., 2008. Autophagy and the ubiquitin-proteasome
system: collaborators in neuroprotection. Biochim. Biophys. Acta 1782, 691–699.
Oliveira, C.V., Grigoletto, J., Funck, V.R., Ribeiro, L.R., Royes, L.F., Fighera, M.R., Furian,
A.F., Oliveira, M.S., 2015. Evaluation of potential gender-related differences in be-
havioral and cognitive alterations following pilocarpine-induced status epilepticus in
C57BL/6 mice. Physiol. Behav. 143, 142–150.
Paylor, R., Spencer, C.M., Yuva-Paylor, L.A., Pieke-Dahl, S., 2006. The use of behavioral
test batteries, II: effect of test interval. Physiol. Behav. 87, 95–102.
Piotrowska, K., Tarnowski, M., Zgutka, K., Pawlik, A., 2016. Gender differences in re-
sponse to prolonged every-other-day feeding on the proliferation and apoptosis of
hepatocytes in mice. Nutrients 8, 176.
Portbury, S.D., Hare, D.J., Sgambelloni, C., Perronnes, K., Portbury, A.J., Finkelstein, D.I.,
Adlard, P.A., 2017. Trehalose improves cognition in the transgenic Tg2576 mouse
model of Alzheimer’s disease. J. Alzheimers Dis. 60, 549–560.
Rodriguez-Navarro, J.A., Rodriguez, L., Casarejos, M.J., Solano, R.M., Gomez, A.,
Perucho, J., Cuervo, A.M., Garcia de Yebenes, J., Mena, M.A., 2010. Trehalose
ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing
mice through autophagy activation. Neurobiol. Dis. 39, 423–438.
Sarkar, S., Chigurupati, S., Raymick, J., Mann, D., Bowyer, J.F., Schmitt, T., Beger, R.D.,
Hanig, J.P., Schmued, L.C., Paule, M.G., 2014. Neuroprotective effect of the chemical
chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
Neurotoxicology 44, 250–262.
Schaeffer, V., Lavenir, I., Ozcelik, S., Tolnay, M., Winkler, D.T., Goedert, M., 2012.
Stimulation of autophagy reduces neurodegeneration in a mouse model of human
tauopathy. Brain 135, 2169–2177.
Sobocanec, S., Balog, T., Sverko, V., Marotti, T., 2003. Sex-dependent antioxidant enzyme
activities and lipid peroxidation in ageing mouse brain. Free Radic. Res. 37, 743–748.
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N.R., Doi, H., Kurosawa, M., Nekooki,
M., Nukina, N., 2004. Trehalose alleviates polyglutamine-mediated pathology in a
mouse model of Huntington disease. Nat. Med. 10, 148–154.
Tanida, I., Ueno, T., Kominami, E., 2008. LC3 and autophagy. Methods Mol. Biol. 445,
77–88.
Tanji, K., Miki, Y., Maruyama, A., Mimura, J., Matsumiya, T., Mori, F., Imaizumi, T., Itoh,
K., Wakabayashi, K., 2015. Trehalose intake induces chaperone molecules along with
autophagy in a mouse model of Lewy body disease. Biochem. Biophys. Res. Commun.
465, 746–752.
Tao, Z., Zheng, L.D., Smith, C., Luo, J., Robinson, A., Almeida, F.A., Wang, Z., Olumi, A.F.,
Liu, D., Cheng, Z., 2018. Estradiol signaling mediates gender difference in visceral
adiposity via autophagy. Cell Death Dis. 9, 309.
Villareal, D.T., Fontana, L., Das, S.K., Redman, L., Smith, S.R., Saltzman, E., Bales, C.,
Rochon, J., Pieper, C., Huang, M., Lewis, M., Schwartz, A.V., Group, C.S., 2016. Effect
of two-year caloric restriction on bone metabolism and bone mineral density in non-
obese younger adults: a randomized clinical trial. J. Bone Miner. Res. 31, 40–51.
A. Berry, et al. Experimental Gerontology 129 (2020) 110755
7
